Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Nat Immunol. 2009 May 31;10(7):769–777. doi: 10.1038/ni.1743

Figure 3. Enhanced peripheral population and suppressive activity of S1P1-KO Treg cells.

Figure 3

(a) Flow cytometry of gated CD4 T cells from the spleen and peripheral lymph nodes (PLN) of WT and S1P1-KO mice. The panel on the right shows the proportions of Foxp3+ Treg cells among total CD4+ T cell population, with the mean (+s.d.) calculated from 4 mice of each genotype. (b) Flow cytometry analysis of Treg markers (Foxp3, CD25, GITR and CTLA4) in PLN of WT and S1P1-KO mice. Data are representative of 2 independent experiments. Similar findings were observed in other peripheral lymphoid organs (not shown). (c) In vitro T-cell suppression assays using Foxp3+ CD4SP cells from WT and S1P1-KO mice. The left panel shows a representative proliferative assay of 4 independent experiments, the middle panel is the percentage of suppression with the mean (±s.d.) calculated from 4 experiments, and the right panel shows a representative of 2 independent experiments measuring IL-2 production. (d) In vitro T-cell suppression assays using S1P1-deleted peripheral Treg cells. Foxp3+ Treg cells from the periphery of S1pr1+/+ and S1pr1fl/fl mice were transduced with Cre-expressing retrovirus (Cre-GFP), and sorted GFP+ Treg cells were used in the T-cell suppression assays with different Tconv and Treg ratios; freshly isolated Treg cells were used as a comparison. The left panel is a representative of 3 independent experiments, and the right panel shows the percentage of suppression with the mean (+s.d.) calculated from 3 experiments. *, P < 0.01; **, P < 0.001 (Student’s t-test).

HHS Vulnerability Disclosure